Hanneke E. Hulst

Prof. Dr. Hanneke E. Hulst


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2022 in Cells
Verified
Journal Article
Open access
PDF file
FSFederica Scaroni
Federica Scaroni
CVCaterina Visconte
Caterina Visconte
MSMaria Serpente
Maria Serpente
MGMaria Teresa Golia
Maria Teresa Golia
Martina GabrielliMartina Gabrielli
Martina Gabrielli
CFChiara Fenoglio
Chiara Fenoglio
Cognitive deficits strongly affect the quality of life of patients with multiple sclerosis (MS). However, no cognitive MS biomarkers are currently available. Extracellular vesicles (EVs) contain markers of parental cells and are able to pass from the brain into blood, representing a source of disease biomarkers. The aim of this study was to investigate whether small non-coding microRNAs (miRNAs) targeting synaptic genes and packaged in plasma EVs may reflect cognitive deficits in MS patients. Total EVs were precipitated by Exoquick from the plasma of twenty-six cognitively preserved (CP) and twenty-three cognitively impaired (CI) MS patients belonging to two independent cohorts. Myeloid EVs were extracted by affinity capture from total EVs using Isolectin B4 (IB4). Fourteen miRNAs targeting synaptic genes were selected and measured by RT-PCR in both total and myeloid EVs. Myeloid EVs from CI patients expressed higher levels of miR-150-5p and lower levels of let-7b-5p compared to CP patients. Stratification for progressive MS (PMS) and relapsing-remitting MS (RRMS) and correlation with clinical parameters suggested that these alterations might be attributable to cognitive deficits rather than disease progression. This study identifies miR-150-5p and let-7b-5p packaged in blood myeloid EVs as possible biomarkers for cognitive deficits in MS.

27 December 2022 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Open access
AGArianne Gravesteijn
Arianne Gravesteijn
HBHeleen Beckerman
Heleen Beckerman
EWEline Aj Willemse
Eline Aj Willemse
HHHanneke E. Hulst
Hanneke E. Hulst
BJBrigit A de Jong
Brigit A de Jong
VGVincent de Groot
Vincent de Groot
Neuroinflammation and neurodegeneration are pathological hallmarks of multiple sclerosis (MS). Brain-derived neurotrophic factor (BDNF), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) are blood-based biomarkers for neurogenesis, axonal damage and astrocyte reactivity, respectively. We hypothesize that exercise has a neuroprotective effect on MS reflected by normalization of BDNF, NfL and GFAP levels. To investigate the neuroprotective effect of aerobic training (AT) compared to a control intervention on blood-based biomarkers (i.e. BDNF, NfL, GFAP) in people with MS (pwMS). In the TREFAMS-AT (Treating Fatigue in Multiple Sclerosis - Aerobic Training) study, 89 pwMS were randomly allocated to either a 16-week AT intervention or a control intervention (3 visits to a MS nurse). In this secondary analysis, blood-based biomarker concentrations were measured in 55 patients using Simoa technology. Changes in pre- and post-intervention concentrations were compared and between-group differences were assessed using analysis of covariance (ANCOVA). Confounding effects of age, sex, MS-related disability assessed using the Expanded Disability Status Scale (EDSS), MS duration, use of disease-modifying medication, and Body Mass Index were considered. Blood samples were available for 30 AT and 25 control group participants (mean age 45.6 years, 71% female, median disease duration 8 years, median EDSS score 2.5). Within-group changes in both study groups were small and non-significant, with the exception of BDNF in the control group (median (interquartile range) -2.1 (-4.7; 0)). No between-group differences were found for any biomarker: BDNF (β = 0.11, 95%CI (-3.78 to 4.00)), NfL (β = -0.04, 95%CI (-0.26 to 0.18)), and GFAP (β = -0.01, 95%CI (-0.16 to 0.15)), adjusted for confounders. Aerobic exercise therapy did not result in statistically significant changes in the tested neuro-specific blood-based biomarkers in people with MS. this study is registered under number ISRCTN69520623 (https://www.isrctn.com/ISRCTN695206).

ADAnna van Duijnhoven
Anna van Duijnhoven
JVJuriena D. de Vries
Juriena D. de Vries
HHHanneke E. Hulst
Hanneke E. Hulst
MDMargot Van der Doef
Margot Van der Doef
Compromised Sustainable Employability (SE) of medical doctors is a concern for the viability of healthcare and, thus, for society as a whole. This study (preregistration: ISRCTN15232070) will assess the effect of a two-year organizational-level workplace intervention using a Participatory Action Research (PAR) approach on the primary outcome SE (i.e., burnout complaints, work engagement, and job satisfaction) and secondary outcomes (i.e., turnover intention, occupational self-efficacy, and perceived impact on health/well-being) in medical doctors. It will also examine whether changes in Psychosocial Safety Climate (PSC), job characteristics (i.e., job demands and resources), and perceived impact on the work situation mediate these effects, and which process factors (i.e., degree of actual implementation of changes, information provision, management support, medical doctors’ involvement, and mental models) are important to the intervention’s success. A pre-post design will be used, including 24 groups of medical doctors (approximately N = 650). Data will be collected at four measurement points (a pre-test, two intermediate evaluations, and a post-test) and analyzed using linear mixed-effect models. The results will provide insights into the effectiveness of the intervention in promoting SE and will inform future organizational-level workplace interventions about the mediators and factors in the implementation process that contribute to its effects.

4 September 2023 in Frontiers in Rehabilitation Sciences
Verified
Journal Article
Open access
HHHanneke E. Hulst
Hanneke E. Hulst
EDEkaterina Dobryakova
Ekaterina Dobryakova
SCSilvana L. Costa
Silvana L. Costa
SDSarah J. Donkers
Sarah J. Donkers
Editorial: Cognitive rehabilitation: a multidisciplinary approach